Interpretation of The 2016 European Thyroid Association/European Group on Graves Orbitopathy Guidelines for the management of Graves orbitopathy

Long Jian; Liu Chun

doi:10.13406/j.cnki.cyxb.001053

您当前的位置：

首页 >

文章列表页 >

Interpretation of The 2016 European Thyroid Association/European Group on Graves Orbitopathy Guidelines for the management of Graves orbitopathy

更新时间：2024-01-17

- Interpretation of The 2016 European Thyroid Association/European Group on Graves Orbitopathy Guidelines for the management of Graves orbitopathy
- Journal of Chongqing Medical University Vol. 41, Issue 11, Pages: 1180-1182(2016)
- 作者机构：
  
  重庆医科大学附属第一医院内分泌科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.001053
  CLC： R581;R771.3
- Published：2016，
扫描看全文
[1]龙健,刘纯.2016年欧洲甲状腺协会/欧洲格雷夫斯眼病专家组格雷夫斯眼病指南解读[J].重庆医科大学学报,2016,41(11):1180-1182.

Long Jian, Liu Chun. Interpretation of The 2016 European Thyroid Association/European Group on Graves Orbitopathy Guidelines for the management of Graves orbitopathy. [J]. Journal of Chongqing Medical University 41(11):1180-1182(2016)
[1]龙健,刘纯.2016年欧洲甲状腺协会/欧洲格雷夫斯眼病专家组格雷夫斯眼病指南解读[J].重庆医科大学学报,2016,41(11):1180-1182. DOI： 10.13406/j.cnki.cyxb.001053.

Long Jian, Liu Chun. Interpretation of The 2016 European Thyroid Association/European Group on Graves Orbitopathy Guidelines for the management of Graves orbitopathy. [J]. Journal of Chongqing Medical University 41(11):1180-1182(2016) DOI： 10.13406/j.cnki.cyxb.001053.

摘要

时隔8年

欧洲甲状腺协会/欧洲格雷夫斯眼病专家组依据最新循证医学证据

更新了格雷夫斯眼病（Graves orbitopathy

GO）治疗指南。新指南针对GO的评估、治疗进行了全面讨论

仍然强调依据GO严重程度和活动度

以及生活质量（quality of life

Qo L）评分选择治疗方案。新指南有两大新亮点:1对轻度GO患者

推荐6个月的硒补充治疗;2对中重度活动性GO患者

指南明确提出一线、二线治疗方案

强调大剂量糖皮质激素静脉冲击治疗是一线治疗方案。

Abstract

Eight years later

the European Thyroid Association(ETA)commissioned European Group on Graves Orbitopathy(EUGOGO)updated Graves orbitopathy(GO)guidelines

based on the latest evidence-based medicine. The evaluation and treatment of the GO are comprehensively discussed in the new guidelines

and the new guideline emphasizes that the treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient’s quality of life. There are two new luminescent spots:a 6-month course of selenium supplementation is recommended in mild GO;the first and second choice of treatment for moderate-to-severe and active GO is also proposed. High-dose glucocorticoids(GCs)via the intravenous route is recommended as the first choice of treatment.

关键词

格雷夫斯眼病生活质量糖皮质激素康复治疗

Keywords

Graves orbitopathyquality of lifeglucocorticoidsrehabilitative surgery

references

Views

493

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Impact of laparoscopic nephron-sparing nephrectomy on renal function and prognosis in patients with renal cell carcinoma

Efficacy and quality of life evaluation of intravesical instillation of Nocardia rubra cell wall skeleton versus bacille Calmette-Guérin after surgery for non-muscle invasive bladder cancer： a retrospective study based on 2-year clinical follow-up

Effects of continuative care on postoperative life quality of patients with Miles in China:a systematic review

Comparison of quality of life after cystectomy and different urinary diversions for bladder cancer

The influence of risperidone and conventional antipsychotics on the life quality of the patients with schizophrenia at their recovery stage

Related Author

He Weiyang

Gou Xin

Ou Yangjie

Lan Jintao

Tong Hang

Yin Hubin

Li Tinghao

Chen Wenqiang

Related Institution

Department of Urology，The First Affiliated Hospital of Chongqing Medical University

Department of Urological Surgery， The Second People’s Hospital of Yibin

Department of Urological Surgery，Sichuan Provincial People’s Hospital

Department of Urological Surgery，Chengdu Second People’s Hospital

Department of Nursing,Jiangsu Cancer Hospital

⁰